Skip to main content
. 2001 Apr;39(4):1303–1310. doi: 10.1128/JCM.39.4.1303-1310.2001

TABLE 4.

Follow-up of the patients with primary HIV-1 infection

Patient no.a Follow-up Proviral HIV-1 DNA (copies/106 PBMC) at:
QCVc (IU/106 PBMC) Plasma HIV-1 RNA (copies/ml) No. of cells/mm3
60°C 65°Cb CD4+ CD8+
1 D0 1,342 1,025 32.9 >750,000 621 1,454
M1 362 449 <0.1 1,208 620 456
M6 146 116 <0.1 72 501 571
M12 44 25 <0.1 <50 645 685
2 D0 923 0 166.3 >750,000 813 745
M1 212 0 <0.1 NDd 859 756
M6 48 0 <0.1 <50 704 558
M12 21 0 <0.1 <50 887 684
3 D0 676 331 2.9 57,161 417 1,124
M1 288 355 3.1 324 463 748
M6 147 91 <0.1 <50 658 559
M12 0 <10 <0.1 <50 650 619
4 D0 436 105 24.2 52,674 438 1,826
M1 369 27 0.6 940 659 1,070
M6 175 9 <0.1 <50 828 1,118
M12 72 10 <0.1 <50 758 778
5 D0 266 <10 ND 128,100 663 743
M4 0 <10 <0.1 ND 831 648
M6 20 <10 <0.1 105 985 788
M12 <10 0 <0.1 <50 1,216 998
6 D0 259 0 32.9 404,906 258 1,632
M1 210 0 2.1 11,251 604 1,203
M6 159 0 <0.1 <50 711 979
M12 38 0 <0.1 <50 760 925
7 D0 155 <10 16.2 181,988 502 441
M1 32 <10 0.3 3,552 740 332
M6 12 <10 <0.1 <50 738 258
M12 <10 19 <0.1 <50 1,003 404
8 D0 105 26 ND 46,029 ND ND
M1 30 <10 <0.1 284 485 798
M6 <10 <10 <0.1 <50 546 693
M12 0 <10 <0.1 <50 637 986
9 D0 10 <10 2.5 89,049 367 454
M3 0 <10 <0.1 <50 177 130
M6 <10 <10 <0.1 <50 582 466
M15 0 <10 <0.1 <50 590 407
10 D0 9,182 ND 35.0 >750,000 261 1,783
M12 53 ND <0.1 <50 508 381
11 D0 1,168 ND 32.9 57,480 543 625
M12 358 ND <0.1 178 746 723
12 D0 963 ND 24.2 100,740 306 1,193
M12 245 ND <0.1 <50 454 861
13 D0 707 ND 9.1 139,120 534 1,595
M12 108 ND <0.1 75 661 610
14 D0 466 ND 17.0 178,000 238 938
M12 10 ND <0.1 <50 188 776
15 D0 143 ND 24.2 254,400 600 3,186
M12 38 ND <0.1 <200 1,113 1,089
16 D0 42 ND 24.0 28,960 270 450
M12 16 ND <0.1 <50 505 355
a

Patients 1 to 9 were treated with lamivudine, stavudine and indinavir and patients 10 to 16 were treated with zidovudine, lamivudine and didanosine and monitored as described in Materials and Methods. 

b

For patients 1 to 9, proviral HIV-1 DNA was also quantified with a PCR annealing temperature of 65°C, instead of 60°C. 

c

QCV, quantitative cellular viremia. 

d

ND, not determined.